Initial data from early clinical trials show that mesenchymal stem cells could potentially stop the virus, calm the immune response and repair tissue damage caused by COVID-19. As the pandemic continues, the race is truly on to find an effective treatment for...
A new phase II clinical trial has indicated that umbilical cord blood infusions are safe and are associated with improved social and communication abilities in children with autism. Results from the study show that umbilical cord blood infusion were safe and well...
As we continue with Cord Blood Awareness month, we will reflect on some of the most revolutionary clinical trials using umbilical cord blood over the last two decades. Cord blood and brain injury Traumatic brain injury (TBI) is a major cause of disability and...
Cells4Life is proud to announce our membership of the All-Party Parliamentary Group for Longevity (APPG). Our aim is to deliver 5 extra years of healthy life expectancy to all British citizens by 2035 while minimising health inequalities. Regenerative medicine will...
Researchers in Abu Dhabi have developed a ground breaking stem cell treatment for COVID-19 patients with initial data showing promising results. Stem cells can currently treat a wide array of conditions, from immune disorder to blood cancers – and this list...
The seven-time World Champion driver, Michael Schumacher, is set to undergo stem cell therapy in an attempt to regenerate his nervous system. Back in 2013, Schumacher suffered a severe brain injury in a skiing accident. Since sustaining the severe life altering injury...
